Stephen M. Condon
Keine laufenden Positionen mehr
Profil
Stephen M.
Condon worked as a Principal at Shire ViroPharma, Inc. and Rhone Poulenc Rorer.
He also worked as Vice President-Chemistry at TetraLogic Pharmaceuticals Corp.
Condon holds a doctorate degree from the University of Pennsylvania, a graduate degree from the University of Georgia, and an undergraduate degree from the University of Massachusetts.
Ehemalige bekannte Positionen von Stephen M. Condon
Unternehmen | Position | Ende |
---|---|---|
Rhone Poulenc Rorer
Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Corporate Officer/Principal | 01.01.2000 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Corporate Officer/Principal | - |
TETRALOGIC PHARMACEUTICALS CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Stephen M. Condon
University of Pennsylvania | Doctorate Degree |
University of Massachusetts | Undergraduate Degree |
University of Georgia | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
Private Unternehmen | 2 |
---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Rhone Poulenc Rorer
Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Process Industries |